Ayretrade Inc (SUMM) 0.0610 $SUMM
Summit to Present at Needham and Company's Annual Healthcare Conference
GlobeNewswire - Tue Apr 07, 6:10AM CDT
Summit Therapeutics plc (Nasdaq:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, announces that Mr. Glyn Edwards, Summit's Chief Executive Officer, is scheduled to present at Needham and Company's 14 Annual Healthcare Conference at 11:20am EDT (4:20pm BST) on 15 April 2015 in New York City.
SMMT: 13.00 (-0.20)
Summit Financial Resources, Inc. Names Joseph Spada, CFP® 2014 Leading Financial Advisor
PR Newswire - Tue Mar 24, 2:51PM CDT
One of the largest independent financial planning and wealth management firms in the Northeast, Summit Financial Resources, Inc., announced today that Joseph Spada, CFP® was named the firm's 2014 Leading Financial Advisor.
Summit Therapeutics Announces Exercise of Over-Allotment Option
GlobeNewswire - Wed Mar 18, 1:15PM CDT
Summit Therapeutics plc (Nasdaq:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 517,500 American Depositary Shares ("ADSs"
at the initial public offering price of $9.90 per ADS, less underwriting discounts and commissions. After the over-allotment closing, the total number of ADSs sold by Summit in its initial public offering has increased to 3,967,500. Each ADS represents five ordinary shares of Summit. Summit's ordinary shares will continue to trade on the AIM market of the London Stock Exchange.
SMMT: 13.00 (-0.20)
Point.360 Announces New Financing
PR Newswire - Thu Feb 19, 8:00AM CST
Point.360 (OTCQX: PTSX), a leading provider of integrated media management services, today announced that it had entered into a financing agreement with Summit Financial Resources, L.P. which provides up to $2 million of credit based on eligible accounts receivable. The agreement provides that interest is calculated at 1.5% over prime rate plus a monthly maintenance fee of 0.6% of the amount outstanding under the agreement. Amounts due under the agreement are secured by all of the Company's accounts receivable and other personal property.
Rocky Mountain Ayre, Inc., Formerly Known as AyreTrade, Inc., has Officially Changed its Corporate Name; New OTC Markets Symbol is: RMTN
ACCESSWIRE - Thu Feb 12, 11:27AM CST
DOVER, DE / ACCESSWIRE / February 12, 2015 / Rocky Mountain Ayre, Inc. (OTC Pink: RMTN) (PINKSHEETS: RMTN), a holding company, is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA), to officially change its name from AyreTrade, Inc. (OTCQB: SUMM) (PINKSHEET: SUMM). The new trading symbol issued is: RMTN.
Summit Financial Group Reports Corrected Book Value Per Share and Tangible Book Value Per Share at December 31, 2014
GlobeNewswire - Wed Jan 28, 11:53AM CST
Summit Financial Group, Inc. ("Company" or "Summit" (Nasdaq:SMMF) is reporting a correction to the book value per common share and the tangible book value per common share, originally reported on page 11 of the release titled "Summit Financial Group Reports Fourth Quarter 2014 Results" issued earlier today. As of December 31, 2014, corrected book value per common share is $12.60 versus the $13.57 book value per common share reported earlier, and corrected tangible book value per share is $11.86 versus the $12.78 tangible book value per common share reported earlier.
SMMF: 12.03 (+0.25)
Summit Financial Group Reports Fourth Quarter 2014 Results
GlobeNewswire - Wed Jan 28, 5:00AM CST
Summit Financial Group, Inc. ("Company" or "Summit" (Nasdaq:SMMF) today reported fourth quarter 2014 net income applicable to common shares of $3.01 million, or $0.32 per diluted share, compared to $2.59 million, or $0.29 per diluted share, for the fourth quarter of 2013, representing an increase of 16.0 percent, or 10.3 percent per diluted share. Q4 2014 earnings compared to Q4 2013 were positively impacted by a $948,000 increase in net interest income and a $1.0 million decline in provision for loan losses, but were negatively impacted by a $686,000 increase in noninterest expense, which included a fraud loss of $461,000.
SMMF: 12.03 (+0.25)
AyreTrade, Inc. Has Completed its Purchase of a Controlling Interest in the Squire's Bistro, Inc., a Restaurant Located in Western Massachusetts
ACCESSWIRE - Mon Dec 22, 11:33AM CST
DOVER, DE / ACCESSWIRE / December 22, 2014 / AyreTrade, Inc., a holding company (OTC Pink: SUMM) (PINKSHEETS: SUMM), is pleased to announce that it has completed its purchase of a controlling interest in Squire's Bistro, Inc., a restaurant located in Western Massachusetts.
Summit Financial Group Reports Third Quarter 2014 Results
GlobeNewswire - Wed Oct 29, 5:00AM CDT
Summit Financial Group, Inc. ("Company" or "Summit" (Nasdaq:SMMF) today reported third quarter 2014 net income applicable to common shares of $3.14 million, or $0.35 per diluted share, compared to $2.08 million, or $0.24 per diluted share, for the third quarter of 2013, representing an increase of 51.3 percent, or 45.8 percent per diluted share. Q3 2014 earnings compared to Q3 2013 were positively impacted by a $1.54 million increase in net interest income and a $750,000 decline in provision for loan losses, but were negatively impacted by a $926,000 increase in write-downs of foreclosed properties.
SMMF: 12.03 (+0.25)
AyreTrade, Inc. Signs Letter of Intent to Acquire a Marijuana Accessories Company
ACCESSWIRE - Wed Aug 27, 2:28PM CDT
DOVER, DE / ACCESSWIRE / August 27, 2014 / AyreTrade, Inc., a holding company that will be expanding its presence in the medical marijuana industry (OTCPINK: SUMM) is pleased to announce that it has signed a LOI to purchase a marijuana accessories company. This company is located in Colorado and has carved out a niche in this unique and expanding industry.
Summit Financial Group Reports Second Quarter 2014 Results
GlobeNewswire - Wed Jul 30, 5:00AM CDT
Summit Financial Group, Inc. ("Company" or "Summit" (Nasdaq:SMMF) today reported second quarter 2014 net income applicable to common shares of $2.24 million, or $0.25 per diluted share, compared to $1.02 million, or $0.13 per diluted share, for the second quarter of 2013, representing an increase of 118.9 percent, or 92.3 percent per diluted share. Q2 2014 earnings compared to Q2 2013 were positively impacted by a $532,000 decline in write-downs of foreclosed properties and an $816,000 increase in net interest income.
SMMF: 12.03 (+0.25)
RCS Capital Corporation Completes Acquisition of Summit Financial Services Group
PR Newswire - Wed Jun 11, 6:07PM CDT
RCS Capital Corporation ("RCAP" (NYSE: RCAP), announced today that it has closed its previously announced acquisition of Summit Financial Services Group, Inc. ("Summit" (OTC: SFNS), an independent broker-dealer headquartered in Boca Raton, Florida.
RCAP: 9.39 (-0.35)
Summit to Present at Needham and Company's Annual Healthcare Conference
GlobeNewswire - Tue Apr 07, 6:10AM CDT
Summit Therapeutics plc (Nasdaq:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, announces that Mr. Glyn Edwards, Summit's Chief Executive Officer, is scheduled to present at Needham and Company's 14 Annual Healthcare Conference at 11:20am EDT (4:20pm BST) on 15 April 2015 in New York City.
SMMT: 13.00 (-0.20)
Summit Financial Resources, Inc. Names Joseph Spada, CFP® 2014 Leading Financial Advisor
PR Newswire - Tue Mar 24, 2:51PM CDT
One of the largest independent financial planning and wealth management firms in the Northeast, Summit Financial Resources, Inc., announced today that Joseph Spada, CFP® was named the firm's 2014 Leading Financial Advisor.
Summit Therapeutics Announces Exercise of Over-Allotment Option
GlobeNewswire - Wed Mar 18, 1:15PM CDT
Summit Therapeutics plc (Nasdaq:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 517,500 American Depositary Shares ("ADSs"
at the initial public offering price of $9.90 per ADS, less underwriting discounts and commissions. After the over-allotment closing, the total number of ADSs sold by Summit in its initial public offering has increased to 3,967,500. Each ADS represents five ordinary shares of Summit. Summit's ordinary shares will continue to trade on the AIM market of the London Stock Exchange. SMMT: 13.00 (-0.20)
Point.360 Announces New Financing
PR Newswire - Thu Feb 19, 8:00AM CST
Point.360 (OTCQX: PTSX), a leading provider of integrated media management services, today announced that it had entered into a financing agreement with Summit Financial Resources, L.P. which provides up to $2 million of credit based on eligible accounts receivable. The agreement provides that interest is calculated at 1.5% over prime rate plus a monthly maintenance fee of 0.6% of the amount outstanding under the agreement. Amounts due under the agreement are secured by all of the Company's accounts receivable and other personal property.
Rocky Mountain Ayre, Inc., Formerly Known as AyreTrade, Inc., has Officially Changed its Corporate Name; New OTC Markets Symbol is: RMTN
ACCESSWIRE - Thu Feb 12, 11:27AM CST
DOVER, DE / ACCESSWIRE / February 12, 2015 / Rocky Mountain Ayre, Inc. (OTC Pink: RMTN) (PINKSHEETS: RMTN), a holding company, is pleased to announce that it has received approval from the Financial Industry Regulatory Authority (FINRA), to officially change its name from AyreTrade, Inc. (OTCQB: SUMM) (PINKSHEET: SUMM). The new trading symbol issued is: RMTN.
Summit Financial Group Reports Corrected Book Value Per Share and Tangible Book Value Per Share at December 31, 2014
GlobeNewswire - Wed Jan 28, 11:53AM CST
Summit Financial Group, Inc. ("Company" or "Summit"
(Nasdaq:SMMF) is reporting a correction to the book value per common share and the tangible book value per common share, originally reported on page 11 of the release titled "Summit Financial Group Reports Fourth Quarter 2014 Results" issued earlier today. As of December 31, 2014, corrected book value per common share is $12.60 versus the $13.57 book value per common share reported earlier, and corrected tangible book value per share is $11.86 versus the $12.78 tangible book value per common share reported earlier. SMMF: 12.03 (+0.25)
Summit Financial Group Reports Fourth Quarter 2014 Results
GlobeNewswire - Wed Jan 28, 5:00AM CST
Summit Financial Group, Inc. ("Company" or "Summit"
(Nasdaq:SMMF) today reported fourth quarter 2014 net income applicable to common shares of $3.01 million, or $0.32 per diluted share, compared to $2.59 million, or $0.29 per diluted share, for the fourth quarter of 2013, representing an increase of 16.0 percent, or 10.3 percent per diluted share. Q4 2014 earnings compared to Q4 2013 were positively impacted by a $948,000 increase in net interest income and a $1.0 million decline in provision for loan losses, but were negatively impacted by a $686,000 increase in noninterest expense, which included a fraud loss of $461,000. SMMF: 12.03 (+0.25)
AyreTrade, Inc. Has Completed its Purchase of a Controlling Interest in the Squire's Bistro, Inc., a Restaurant Located in Western Massachusetts
ACCESSWIRE - Mon Dec 22, 11:33AM CST
DOVER, DE / ACCESSWIRE / December 22, 2014 / AyreTrade, Inc., a holding company (OTC Pink: SUMM) (PINKSHEETS: SUMM), is pleased to announce that it has completed its purchase of a controlling interest in Squire's Bistro, Inc., a restaurant located in Western Massachusetts.
Summit Financial Group Reports Third Quarter 2014 Results
GlobeNewswire - Wed Oct 29, 5:00AM CDT
Summit Financial Group, Inc. ("Company" or "Summit"
(Nasdaq:SMMF) today reported third quarter 2014 net income applicable to common shares of $3.14 million, or $0.35 per diluted share, compared to $2.08 million, or $0.24 per diluted share, for the third quarter of 2013, representing an increase of 51.3 percent, or 45.8 percent per diluted share. Q3 2014 earnings compared to Q3 2013 were positively impacted by a $1.54 million increase in net interest income and a $750,000 decline in provision for loan losses, but were negatively impacted by a $926,000 increase in write-downs of foreclosed properties. SMMF: 12.03 (+0.25)
AyreTrade, Inc. Signs Letter of Intent to Acquire a Marijuana Accessories Company
ACCESSWIRE - Wed Aug 27, 2:28PM CDT
DOVER, DE / ACCESSWIRE / August 27, 2014 / AyreTrade, Inc., a holding company that will be expanding its presence in the medical marijuana industry (OTCPINK: SUMM) is pleased to announce that it has signed a LOI to purchase a marijuana accessories company. This company is located in Colorado and has carved out a niche in this unique and expanding industry.
Summit Financial Group Reports Second Quarter 2014 Results
GlobeNewswire - Wed Jul 30, 5:00AM CDT
Summit Financial Group, Inc. ("Company" or "Summit"
(Nasdaq:SMMF) today reported second quarter 2014 net income applicable to common shares of $2.24 million, or $0.25 per diluted share, compared to $1.02 million, or $0.13 per diluted share, for the second quarter of 2013, representing an increase of 118.9 percent, or 92.3 percent per diluted share. Q2 2014 earnings compared to Q2 2013 were positively impacted by a $532,000 decline in write-downs of foreclosed properties and an $816,000 increase in net interest income. SMMF: 12.03 (+0.25)
RCS Capital Corporation Completes Acquisition of Summit Financial Services Group
PR Newswire - Wed Jun 11, 6:07PM CDT
RCS Capital Corporation ("RCAP"
(NYSE: RCAP), announced today that it has closed its previously announced acquisition of Summit Financial Services Group, Inc. ("Summit" (OTC: SFNS), an independent broker-dealer headquartered in Boca Raton, Florida. RCAP: 9.39 (-0.35)
